Augment Health, Inc.

Augment Health, Inc. is developing a noninvasive bladder monitor + AI algorithm for patients with NLUTD. Today's in-clinic diagnostics face a 44% failure rate and limited access for 7M patients. Our at-home device improves pressure data reliability with proprietary AI analysis, reducing specialist burden and improving access. Learn More

Cystotech

Cystotech is dedicated to transforming the clinical pathway for bladder cancer patients worldwide. Our innovative AI-driven software provides clinicians with real-time decision support during Cystoscopy, aiming to enhance patient outcomes.
We strive to improve the quality of life for bladder cancer patients while reducing the financial burden on healthcare providers and payers. Learn More

EndoTheia, Inc

ImmunoPDT Ltd

A T-Cell mediated immune response to the patient's Prostate Cancer is created while the Photo Dynamic Therapy (PDT) treatment kills the whole of the cancer in the gland. 10-12 year audit shows no harm and stable urinary, bowel and erectile function.13 Relapsed patients have an 84% PCa specific survival rate, median of 16 years. Two deaths from PCa. 24 Primary patients have a 74% PCa specific survival rate, median of 15 years. Four deaths from PCa, five from other causes. Learn More

Insight Medbotics

Insight Medbotics is developing MRI-compatible robotics, a new category of robotics designed to solve MRI access for urologists across care settings and revolutionize precision in prostate cancer care. Learn More

MEDiThings Co., Ltd.

MEDiThings, an AI healthcare startup from South Korea, pioneers wearable biosensing technology. MEDiThings develops non-invasive urology solutions using a NIRS-centered platform with integrated sensing technologies. Our system provides real-time bladder information that helps individuals manage urinary health. Learn More

Multi4 Medical

Multi4 Medical: FDA-cleared, globally patented 6-in-1 single-use device for complete outpatient NMIBC treatment. Integrates anesthesia, resection, automated specimen retrieval & fulguration—no instrument exchanges. 20-minute, single-operator procedures. Learn More

Nowwell

Nowwell is a Medtech company developing next-generation catheters. We enhance patient care and help ensure that incontinence and retention no longer limit lives. Learn More

ProArc

ProArc Medical is an interventional urology company developing a patented self-embedding implant for BPH-related LUTS. Interim multicenter pilot study results show significant, above-expected IPSS improvement and fast post-procedure recovery. Learn More

Relief S.r.l.

Relief S.r.l. is a medtech startup focused on transforming the treatment of stress urinary incontinence with a minimally invasive, removable and reversible solution, while preserving anatomy and patient quality of life. Learn More

Stimuli Technology

Born out of a vision to develop non-invasive and non-drug therapeutic solutions, Stimuli Technology focuses on overactive bladder with Tensi+ MD. This patient-friendly and clinically proven electrostimulation solution reduces OAB symptoms and improves patients’ quality of life. Learn More

Tricol Biomedical Inc

Tricol Biomedical is a medical device company with the mission to significantly reduce patient morbidity and achieve zero preventable deaths due to blood loss. The blood stops here. Learn More

VersaWell

VersaWell Inc., an emerging healthcare company, provides innovative solutions for healthier living. The company is launching UriGent® Bedside Portable Urinal, the first-in-the-world bedside portable urinal for men. UriGent Bedside Urinal is a safe, convenient and dignified alternative for managing personal hygiene and preventing falls associated with dangerous walks to the bathroom at night.

Virchow Medical, Inc.

Our technology allows hospitals to unlock critical molecular data for every cancer patient, enabling precision medicine to save more lives, while building a unique liquid specimen biorepository that generates testing volume for clinical labs and data for targeted therapy development. Learn More

Virtuoso Surgical, Inc.

Virtuoso has developed a groundbreaking robotic surgery system featuring 1-millimeter instruments for rigid endoscopic procedures, providing surgeons with unprecedented two-handed control and dexterity. Their device was recently designated a breakthrough device by FDA for intact removal of bladder tumors. Learn More

Watershed Therapeutics

Watershed Medical is a clinical-stage drug company developing intravesical combination products for bladder cancer. Its platform enables delivery of multiple therapies in a comfortable, bladder-retentive format with passive, non-procedural clearance. Learn More

Xaga Surgical

Xaga Surgical’s Forsvall needle—now in clinical use in the US—aims to raise the standard for TR and TP biopsy with excellent cores, superior targeting and a 96% reduction in bacterial transfer. Designed to address diagnostic accuracy and biopsy-related infections. Learn More